Hand surgery Surgery Hand surgery
Conditions
Interventions
Experimental group: non-steroidal anti-inflammatory drug (NSAID) 1 hour before surgery, 1 daily after surgery.
Both groups (OPA and UAT) will receive the same treatment until their admission in the re
Sponsors
University Hospital of Montreal (CHUM) (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients, either sex, scheduled for trapeziectomy and carpal surgery: 1. Total and partial carpectomy 2. Bone graph 3. Wrist arthrodesis 4. Distal radial arthrotomy
Exclusion criteria
Exclusion criteria: 1. Age under 18 years or older than 75 years 2. Pregnant 3. Allergic to morphine, local anesthetics 4. Suffering from other forms of chronic arthritis or other painful conditions treated chronically (every day) with analgesics (i.e. fibromyalagia) 5. Allergic or intolerant to NSAID (COX2 inhibitors) 6. Consuming anticoagulants which cannot be interrupted 7. Suffering from major cardiovascular problems 8. Suffering from cognitive or psychiatric problems, or drug abuse 9. Other recent hand surgery or axillary surgery with sequels 10. Living alone (no help at home) 11. Unable to understand French or English 12. Without phone access or likely to change address during follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing pain intensity at rest and during active movements measured at 8 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The impact of pain on Quality of Life (QOL) 2. The impact of pain on activities 3. Inflammation 4. Function | — |
Countries
Canada
Outcome results
None listed